Campaign_KeyVisual

Watch the webinar on demand

Dr Philip Gribbon, Assistant Head of Department at Frauenhofer IME – ScreeningPort, describes recent efforts to identify small molecule therapeutics for the treatment of SARS-CoV-2 infection and COVID-19 disease. In this context, he presents approaches to screen libraries of drugs and clinical candidates for potentially therapeutic repurposing.

Watch the webinar on demand

Dr Philip Gribbon and Dr Andrea Beccari discuss the EXSCALATE4CoV (E4C) project, an international research consortium financed by the European Union charged with accelerating drug repurposing to target SARS-Cov2 and building a network of experts, resources and tools to better address potential future pandemics.

Speaker

Dr Philip Gribbon

Dr Philip Gribbon

Assistant Head of Department at Frauenhofer IME - ScreeningPort

.

Dr Andrea Beccari

Dr Andrea Beccari

Head of R&D Platforms & Services at Dompé farmaseutical SpA and Coordinator of the EXSCALATE4CoV (E4C) Project

.

Request more information